| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | semicircular canal morphogenesis | 4.26e-05 | 9 | 23 | 2 | GO:0048752 | |
| GeneOntologyBiologicalProcess | semicircular canal development | 6.50e-05 | 11 | 23 | 2 | GO:0060872 | |
| MousePheno | decreased posterior semicircular canal size | 2.62e-05 | 6 | 19 | 2 | MP:0003164 | |
| MousePheno | decreased lateral semicircular canal size | 3.66e-05 | 7 | 19 | 2 | MP:0003162 | |
| MousePheno | enlarged otoliths | 6.27e-05 | 9 | 19 | 2 | MP:0003143 | |
| MousePheno | abnormal crista ampullaris neuroepithelium morphology | 9.56e-05 | 11 | 19 | 2 | MP:0004409 | |
| MousePheno | absent lateral semicircular canal | 1.35e-04 | 13 | 19 | 2 | MP:0003161 | |
| MousePheno | absent otoliths | 1.82e-04 | 15 | 19 | 2 | MP:0002978 | |
| MousePheno | abnormal superior semicircular canal morphology | 2.08e-04 | 16 | 19 | 2 | MP:0003069 | |
| MousePheno | perinatal lethality, complete penetrance | 2.62e-04 | 712 | 19 | 6 | MP:0011089 | |
| MousePheno | abnormal posterior semicircular canal morphology | 3.28e-04 | 20 | 19 | 2 | MP:0002858 | |
| MousePheno | abnormal lateral semicircular canal morphology | 3.62e-04 | 21 | 19 | 2 | MP:0000037 | |
| MousePheno | decreased otolith number | 3.98e-04 | 22 | 19 | 2 | MP:0003144 | |
| MousePheno | head shaking | 3.98e-04 | 22 | 19 | 2 | MP:0002730 | |
| MousePheno | bidirectional circling | 4.75e-04 | 24 | 19 | 2 | MP:0001395 | |
| MousePheno | abnormal olfactory sensory neuron morphology | 5.15e-04 | 25 | 19 | 2 | MP:0006092 | |
| MousePheno | cleft palate | 5.43e-04 | 289 | 19 | 4 | MP:0000111 | |
| MousePheno | oral cleft | 5.57e-04 | 291 | 19 | 4 | MP:0021164 | |
| MousePheno | abnormal basicranium morphology | 5.81e-04 | 123 | 19 | 3 | MP:0010029 | |
| MousePheno | cleft secondary palate | 6.38e-04 | 127 | 19 | 3 | MP:0009890 | |
| MousePheno | abnormal crista ampullaris morphology | 6.48e-04 | 28 | 19 | 2 | MP:0004249 | |
| MousePheno | abnormal coronary artery morphology | 6.95e-04 | 29 | 19 | 2 | MP:0004111 | |
| MousePheno | abnormal chemoreceptor morphology | 7.44e-04 | 30 | 19 | 2 | MP:0001001 | |
| MousePheno | abnormal otolith morphology | 7.44e-04 | 30 | 19 | 2 | MP:0002894 | |
| MousePheno | abnormal palate morphology | 8.05e-04 | 321 | 19 | 4 | MP:0003755 | |
| MousePheno | postnatal growth retardation | 8.21e-04 | 881 | 19 | 6 | MP:0001732 | |
| MousePheno | abnormal temporal bone petrous part morphology | 8.47e-04 | 32 | 19 | 2 | MP:0030319 | |
| MousePheno | abnormal semicircular canal ampulla morphology | 8.47e-04 | 32 | 19 | 2 | MP:0008488 | |
| MousePheno | abnormal otolithic membrane morphology | 8.47e-04 | 32 | 19 | 2 | MP:0002895 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 9.46e-04 | 1269 | 19 | 7 | MP:0011111 | |
| MousePheno | abnormal postnatal growth | 9.57e-04 | 907 | 19 | 6 | MP:0001731 | |
| MousePheno | abnormal secondary palate morphology | 1.22e-03 | 159 | 19 | 3 | MP:0013550 | |
| MousePheno | abnormal parental behavior | 1.25e-03 | 160 | 19 | 3 | MP:0002068 | |
| MousePheno | abnormal scapula morphology | 1.32e-03 | 40 | 19 | 2 | MP:0000149 | |
| MousePheno | abnormal touch/ nociception | 1.45e-03 | 376 | 19 | 4 | MP:0001968 | |
| MousePheno | hypoalgesia | 1.48e-03 | 170 | 19 | 3 | MP:0003043 | |
| MousePheno | increased cardiomyocyte apoptosis | 1.60e-03 | 44 | 19 | 2 | MP:0003222 | |
| MousePheno | abnormal heart septum morphology | 1.63e-03 | 388 | 19 | 4 | MP:0006113 | |
| MousePheno | abnormal olfactory epithelium morphology | 1.90e-03 | 48 | 19 | 2 | MP:0008789 | |
| MousePheno | head bobbing | 2.14e-03 | 51 | 19 | 2 | MP:0001410 | |
| MousePheno | abnormal respiratory epithelium physiology | 2.14e-03 | 51 | 19 | 2 | MP:0014200 | |
| MousePheno | abnormal cardiomyocyte apoptosis | 2.31e-03 | 53 | 19 | 2 | MP:0003221 | |
| MousePheno | decreased cell proliferation | 2.55e-03 | 739 | 19 | 5 | MP:0000352 | |
| MousePheno | abnormal olfactory system morphology | 2.58e-03 | 56 | 19 | 2 | MP:0005499 | |
| MousePheno | abnormal coronary vessel morphology | 2.86e-03 | 59 | 19 | 2 | MP:0010551 | |
| MousePheno | abnormal semicircular canal morphology | 2.86e-03 | 59 | 19 | 2 | MP:0002428 | |
| Domain | NBPF | 2.38e-12 | 11 | 28 | 5 | PS51316 | |
| Domain | DUF1220 | 2.38e-12 | 11 | 28 | 5 | PF06758 | |
| Domain | NBPF_dom | 2.38e-12 | 11 | 28 | 5 | IPR010630 | |
| Domain | DUF1220 | 5.06e-10 | 9 | 28 | 4 | SM01148 | |
| Domain | ARM-type_fold | 1.55e-03 | 339 | 28 | 4 | IPR016024 | |
| Domain | SANT | 2.54e-03 | 50 | 28 | 2 | SM00717 | |
| Domain | SANT/Myb | 2.74e-03 | 52 | 28 | 2 | IPR001005 | |
| Domain | - | 4.36e-03 | 222 | 28 | 3 | 1.25.10.10 | |
| Domain | ARM-like | 7.49e-03 | 270 | 28 | 3 | IPR011989 | |
| Domain | PDZ | 1.88e-02 | 141 | 28 | 2 | PF00595 | |
| Pubmed | 3.00e-20 | 21 | 31 | 8 | 16079250 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 1.08e-10 | 10 | 31 | 4 | 22973535 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 30821106 | ||
| Pubmed | 1.91e-06 | 233 | 31 | 5 | 37704626 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.95e-06 | 430 | 31 | 6 | 35044719 | |
| Pubmed | 2.11e-05 | 653 | 31 | 6 | 22586326 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.43e-05 | 394 | 31 | 5 | 27248496 | |
| Pubmed | 3.22e-05 | 418 | 31 | 5 | 34709266 | ||
| Pubmed | Lineage-specific gene duplication and loss in human and great ape evolution. | 3.23e-05 | 69 | 31 | 3 | 15252450 | |
| Pubmed | 8.47e-05 | 513 | 31 | 5 | 25798074 | ||
| Pubmed | 1.06e-04 | 538 | 31 | 5 | 28524877 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.54e-04 | 1353 | 31 | 7 | 29467282 | |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 1.64e-04 | 119 | 31 | 3 | 35776542 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.87e-04 | 608 | 31 | 5 | 36089195 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 2.02e-04 | 1415 | 31 | 7 | 28515276 | |
| Pubmed | 2.15e-04 | 1429 | 31 | 7 | 35140242 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.32e-04 | 341 | 31 | 4 | 32971831 | |
| Pubmed | 2.34e-04 | 638 | 31 | 5 | 33239621 | ||
| Pubmed | 2.34e-04 | 638 | 31 | 5 | 31182584 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 2.40e-04 | 1455 | 31 | 7 | 22863883 | |
| Pubmed | 3.29e-04 | 30 | 31 | 2 | 31740976 | ||
| Pubmed | 3.41e-04 | 1084 | 31 | 6 | 11544199 | ||
| Pubmed | 3.43e-04 | 153 | 31 | 3 | 10718198 | ||
| Pubmed | 3.52e-04 | 31 | 31 | 2 | 32546759 | ||
| Pubmed | 3.52e-04 | 31 | 31 | 2 | 21441570 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.78e-04 | 1105 | 31 | 6 | 35748872 | |
| Pubmed | 3.84e-04 | 159 | 31 | 3 | 30581152 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 4.43e-04 | 167 | 31 | 3 | 20362541 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 4.51e-04 | 736 | 31 | 5 | 29676528 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 4.66e-04 | 170 | 31 | 3 | 23314748 | |
| Pubmed | 5.25e-04 | 177 | 31 | 3 | 26206133 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.67e-04 | 774 | 31 | 5 | 15302935 | |
| Pubmed | A proteomic snapshot of the human heat shock protein 90 interactome. | 5.87e-04 | 40 | 31 | 2 | 16263121 | |
| Pubmed | 7.70e-04 | 469 | 31 | 4 | 27634302 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 7.81e-04 | 203 | 31 | 3 | 22083510 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 8.68e-04 | 1294 | 31 | 6 | 30804502 | |
| Pubmed | 8.79e-04 | 486 | 31 | 4 | 20936779 | ||
| Interaction | TERF2IP interactions | 1.65e-05 | 552 | 31 | 7 | int:TERF2IP | |
| Interaction | H2BC8 interactions | 2.17e-05 | 576 | 31 | 7 | int:H2BC8 | |
| Interaction | EN1 interactions | 2.36e-05 | 110 | 31 | 4 | int:EN1 | |
| Interaction | SH3PXD2A interactions | 4.28e-05 | 128 | 31 | 4 | int:SH3PXD2A | |
| Interaction | ESRRB interactions | 4.61e-05 | 262 | 31 | 5 | int:ESRRB | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 8.51e-09 | 404 | 31 | 7 | chr1q21 | |
| Cytoband | 1q21.1 | 1.03e-05 | 62 | 31 | 3 | 1q21.1 | |
| Cytoband | 1p13.3 | 1.01e-03 | 69 | 31 | 2 | 1p13.3 | |
| Cytoband | 1q21.2 | 1.07e-03 | 71 | 31 | 2 | 1q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 8.96e-03 | 211 | 31 | 2 | chr1p13 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.80e-18 | 23 | 27 | 8 | 662 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.23e-04 | 15 | 27 | 2 | 529 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.82e-03 | 53 | 27 | 2 | 532 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.43e-05 | 232 | 29 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.81e-05 | 311 | 29 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.01e-04 | 831 | 29 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.29e-04 | 192 | 29 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| ToppCell | COVID-19_Convalescent|World / Disease condition and Cell class | 7.32e-06 | 181 | 31 | 4 | a62115a8da486fc61225901c72b1ec70bcaf4c36 | |
| ToppCell | Severe-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.25e-05 | 111 | 31 | 3 | 7021009545178fac1f19f3c429bfedb2f38b680d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Solid_Pattern_Predominant_Adenocarcinoma-1|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.94e-05 | 115 | 31 | 3 | 891a2c68472c2a633fc1864a9c3debc3b5ae1b77 | |
| ToppCell | COVID-19-APC-like-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 9.10e-05 | 126 | 31 | 3 | 9f94291b1db020cc0ebf9c8de4e01bd883295672 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.32e-04 | 143 | 31 | 3 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.35e-04 | 144 | 31 | 3 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 152 | 31 | 3 | b8aa62e3cf2b4c252db4bccfa75d881c4fa0a788 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.81e-04 | 159 | 31 | 3 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.81e-04 | 159 | 31 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.09e-04 | 167 | 31 | 3 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-04 | 167 | 31 | 3 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.13e-04 | 168 | 31 | 3 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.13e-04 | 168 | 31 | 3 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.13e-04 | 168 | 31 | 3 | 83b4f817d95daa15ae60668e789f97d8a3b2e6dd | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.13e-04 | 168 | 31 | 3 | c66a61d3ec711796313a2c6d2dc39aedbfc20afd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 173 | 31 | 3 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.40e-04 | 175 | 31 | 3 | f6a6db992e803d36c866a91706b02f67e0fd3e09 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.56e-04 | 179 | 31 | 3 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-04 | 180 | 31 | 3 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 2.74e-04 | 183 | 31 | 3 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-04 | 184 | 31 | 3 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 186 | 31 | 3 | 41e03be964044dae690d566bd078dab3d8045eba | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-04 | 187 | 31 | 3 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-04 | 187 | 31 | 3 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-04 | 187 | 31 | 3 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-04 | 187 | 31 | 3 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-04 | 187 | 31 | 3 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-04 | 187 | 31 | 3 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.96e-04 | 188 | 31 | 3 | e239bcdbd210a398a5850cb6fbf171d402f45a4f | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 3.01e-04 | 189 | 31 | 3 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.05e-04 | 190 | 31 | 3 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.05e-04 | 190 | 31 | 3 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.05e-04 | 190 | 31 | 3 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 3.10e-04 | 191 | 31 | 3 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-04 | 192 | 31 | 3 | d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG-26|World / Primary Cells by Cluster | 3.15e-04 | 192 | 31 | 3 | b8cf9c3c6b954e93f7504d214e39662bfa8f96f5 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.15e-04 | 192 | 31 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-04 | 193 | 31 | 3 | 9661ea0ee7273928c7de2a9f49e853595fa77699 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.20e-04 | 193 | 31 | 3 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-04 | 193 | 31 | 3 | 5f5904cec8b2967154ef2eab3c48f51df53aca4a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.25e-04 | 194 | 31 | 3 | b111d10c99d7ff7eb261cd7786cd9d9a549049b1 | |
| ToppCell | severe-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.25e-04 | 194 | 31 | 3 | 2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-04 | 194 | 31 | 3 | 5bd0f739aa75f387cca7c3b2686493ee2d1ee968 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG|World / Primary Cells by Cluster | 3.25e-04 | 194 | 31 | 3 | 3a4bf6a7fac0e5bdbb4bb17041806d06a75974d9 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.30e-04 | 195 | 31 | 3 | b25c534fc6320d4da6437ef1b27e32a5d5256f3e | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-04 | 198 | 31 | 3 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new|World / Primary Cells by Cluster | 3.45e-04 | 198 | 31 | 3 | 11d2d4d179bc31ef2897d7ceeaf9bed1b20cbdc0 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 3.45e-04 | 198 | 31 | 3 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-04 | 198 | 31 | 3 | a631be84e29c277216d89ec6265bd43e87c1dc86 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-20|World / Primary Cells by Cluster | 3.45e-04 | 198 | 31 | 3 | bce0bc1e3f2257e0f42a1fa6e5b57cf71e4514ba | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new-9|World / Primary Cells by Cluster | 3.45e-04 | 198 | 31 | 3 | c724ef958e14e17a7d8c02b9f842510c0780f635 | |
| ToppCell | Transverse-T_cell-Th1|T_cell / Region, Cell class and subclass | 3.50e-04 | 199 | 31 | 3 | 9271d9d36ffe1c169049d4340258f366916adfaf | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 3.50e-04 | 199 | 31 | 3 | 3feee9f53860b4b2e93ff2360beb2b2b74f51d24 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 3.55e-04 | 200 | 31 | 3 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.55e-04 | 200 | 31 | 3 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.55e-04 | 200 | 31 | 3 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 3dcaeb9f1e387784c299bfe0da1516598f82edf5 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related-Oligodendrocyte/OPC|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 4a57f2f2dc6e2402ac4772b5cd38e033a6f1adee | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.55e-04 | 200 | 31 | 3 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 3.55e-04 | 200 | 31 | 3 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related-Oligodendrocyte/OPC|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 7557ea33c3d080d0fa4ca0c2703279932d01e6d0 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 3.55e-04 | 200 | 31 | 3 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | ea1e3eeddbc398ac97863120f7aa3f17569ca12a | |
| Drug | Pesticides | 1.45e-06 | 150 | 30 | 5 | ctd:D010575 | |
| Disease | systemic scleroderma | 5.72e-05 | 85 | 26 | 3 | EFO_0000717 | |
| Disease | Sezary Syndrome | 2.59e-04 | 27 | 26 | 2 | C0036920 | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 6.59e-04 | 43 | 26 | 2 | EFO_0004471, EFO_0006896 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.69e-03 | 69 | 26 | 2 | DOID:1682 (implicated_via_orthology) | |
| Disease | basophil percentage of granulocytes | 2.43e-03 | 83 | 26 | 2 | EFO_0007995 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVDVECPDVNIEGPE | 2801 | Q09666 | |
| EVCPSAIDPEDGEKK | 221 | Q9H1Y0 | |
| EEPENPAAKEKCEGK | 2176 | Q9P2D1 | |
| IKKDQEEIEDQSPPC | 401 | Q96M43 | |
| DKEKPPCNAQELEEC | 396 | Q96RS6 | |
| EKAETESCPGQEEPK | 3721 | Q8NEZ4 | |
| ESCPGQEEPKLEEQN | 3726 | Q8NEZ4 | |
| KQQKPLEECEDDEGV | 336 | Q96QZ7 | |
| LCNEEEKEQLDPKPQ | 211 | Q8N6Y2 | |
| PNGPNIDKKEEDLED | 816 | Q92598 | |
| KCIEGQEKVACEEPP | 326 | P05160 | |
| QKGKSKDDPDDCPIE | 751 | Q14D04 | |
| KDDPDDCPIELSKVQ | 756 | Q14D04 | |
| PDEEQEKDKEDQPQG | 226 | Q92917 | |
| KPQQKLGDEDEEIDG | 811 | P09884 | |
| KDDIPEEDKGNVKQC | 191 | Q14331 | |
| NKDEEECNEPKGDPE | 501 | Q9ULT8 | |
| CDPDGLSDEEDQKPV | 301 | Q96RY5 | |
| PEKADAENGEKEEVP | 4501 | P21817 | |
| IKKDQEEIEDQSPPC | 401 | Q5VWK0 | |
| IKKDQEEEEDQGPPC | 921 | P0DPF3 | |
| IKKDEEEEEDQDPPC | 996 | Q6P3W6 | |
| KKDEEEEEDQDPPCP | 1241 | Q6P3W6 | |
| IKKDQEEEEDQGPPC | 2216 | Q6P3W6 | |
| KKDQEEEEDQDPPCP | 2461 | Q6P3W6 | |
| IKKDQEEEEDQGPPC | 3436 | Q6P3W6 | |
| IKKDQEEEEDQGPPC | 731 | Q5TI25 | |
| IKKDQEEEEDQGPPC | 481 | Q8N660 | |
| IKKDQEEEEDQDPPC | 481 | A0A087WUL8 | |
| KKDQEEEEDQDPPCP | 726 | A0A087WUL8 | |
| IKKDQEEEEDQDPPC | 1701 | A0A087WUL8 | |
| KKDQEEEEDQGPPCP | 1946 | A0A087WUL8 | |
| IKKDQEEEEDQGPPC | 2921 | A0A087WUL8 | |
| KKDQEEEEDQGPPCP | 3166 | A0A087WUL8 | |
| TKKDQEEEEDQGPPC | 381 | P0DPF2 | |
| KKDQEEEEDQGPPCP | 626 | P0DPF2 | |
| TKKDQEEEEDQGPPC | 1601 | P0DPF2 | |
| KKDQEEEEDQGPPCP | 1846 | P0DPF2 | |
| TKKDQEEEEDQGPPC | 2821 | P0DPF2 | |
| KKDQEEEEDQGPPCP | 3066 | P0DPF2 | |
| TKKDQEEEEDQGPPC | 4041 | P0DPF2 | |
| KKDQEEEEDQGPPCP | 4286 | P0DPF2 | |
| QVPDDLPNVCEEKNE | 1641 | Q5UIP0 | |
| QCVENADLPEGEKKP | 111 | Q99460 | |
| QPIDKIKESQEGDEC | 1071 | A4UGR9 | |
| PPNDPGVEKDKEQEE | 86 | Q9C0A1 | |
| QEEKECEKPQGDEEE | 1051 | P37275 | |
| CQPLKEEDDDEGPVD | 281 | Q8N1G0 | |
| QSKEDKEDQEPIRCP | 941 | Q9UL68 |